Course Code: BP102T
Unit II Overview
Unit II: Pharmaceutical Calculations. This unit connects accurate measurement and calculation with dose interpretation, dosage forms and formulation ingredients.
Topics Covered – Syllabus Coverage
| Required topic | Coverage |
|---|---|
| Metric weights and measures; scientific notation | Sections 2.1-2.3 |
| Percentage and ratio strengths; dilution | Sections 2.4-2.6 |
| Alligation | Section 2.7 |
| Proof spirit | Section 2.8 |
| Isotonic solutions | Sections 2.9-2.11 |
| Geometric dilution | Section 2.12 |
| Posology: age, weight and body surface area | Sections 2.13-2.16 |
| Routes of administration | Section 2.17 |
| Classification of dosage forms | Section 2.18 |
| APIs: definition, ideal characteristics, importance | Section 2.19 |
| Excipients: definition, ideal characteristics, importance | Sections 2.20-2.21 |
Revision and Assessment
Sections 2.22-2.24 provide integrated problems, quick revision and examination practice with numerical answers.
Learning Outcomes
- Convert metric quantities and express very large or small values using scientific notation.
- Calculate amounts, strengths, dilutions and mixture proportions with units.
- Distinguish tonicity from total particle concentration and apply stated isotonicity data.
- Explain geometric dilution and check the final powder mass.
- Interpret age-, weight- and surface-area-based calculation methods.
- Compare routes and dosage forms; explain the functions of APIs and excipients.
Essential Symbols
| Symbol | Meaning |
|---|---|
| C | Concentration, with its basis stated |
| V | Volume |
| w / m | Mass |
| E | Sodium chloride equivalent |
| BSA | Body surface area |
| q.s. | Sufficient quantity |
| ABV | Alcohol by volume |
The calculation principle: Write the quantity, unit and concentration basis together. Keep the required final quantity visible throughout the calculation.
Learning Examples
Numerical examples use stated assumptions and fictional drug names where doses are involved. They teach calculation methods; an actual dose is determined from medicine-specific instructions and patient factors.
2.1 Measurement and Calculation Foundations
Pharmaceutical calculations are the mathematical operations used to determine ingredient quantities, solution strengths, doses and the quantities supplied. A correct number with the wrong unit is an incorrect pharmaceutical result.
Mass, Volume and Length
| Quantity | Common units | Typical use |
|---|---|---|
| Mass | kg, g, mg, microgram | Weigh an API or excipient |
| Volume | L, mL | Measure liquid; state final volume |
| Length | m, cm, mm | Height or apparatus dimensions |
| Area | m², cm² | Body surface area or surface dimensions |
In strict SI terminology, kilogram is the base unit of mass and metre is the base unit of length. The litre is accepted for use with SI; pharmacy commonly measures volume in litres and millilitres. “Weight” is often used in dispensing for the mass being weighed, although physical weight is a force.
A Reliable Calculation Sequence
- Step 1: Read the entire question and identify what must be found.
- Step 2: List the supplied numbers with their units and concentration basis.
- Step 3: Convert quantities to compatible units.
- Step 4: Choose a relationship and substitute the values.
- Step 5: Retain sufficient working precision and round only the final answer appropriately.
- Step 6: Check units, magnitude and whether the result satisfies the original question.
Dimensional analysis: A conversion factor is a ratio equal to one, such as 1000 mg / 1 g. Arrange it so that the unwanted unit cancels. A remaining unit tells whether the answer is a mass, volume or concentration.
Example: 0.25 g × (1000 mg / 1 g) = 250 mg. The g cancels; mg remains. The numerical value becomes larger because a milligram is a smaller unit.
2.2 Metric Conversions and Measurement Practice
Diagram labels: kg → g → mg → micrograms: multiply by 1000 at each downward step; divide by 1000 at each upward step.
Explanation: Moving from a larger unit to a smaller unit increases the numerical value. Reverse the operation when converting back; the physical amount stays unchanged.
Conversions to Remember
| Relationship | Equivalent |
|---|---|
| 1 kg | 1000 g |
| 1 g | 1000 mg |
| 1 mg | 1000 micrograms |
| 1 L | 1000 mL |
| 1 mL | 1 cm³ |
| 1 m | 100 cm = 1000 mm |
Do not convert g into mL by assuming they are interchangeable. For a material of known density, mass = density × volume. Water-based approximations cannot be applied automatically to oils, syrups or other liquids.
Worked Example: Three Conversions
- Step 1: Convert 750 micrograms to mg: 750 / 1000 = 0.75 mg.
- Step 2: Convert 0.008 g to mg: 0.008 × 1000 = 8 mg.
- Step 3: Convert 125 mL to L: 125 / 1000 = 0.125 L.
Correct Notation and Measuring Technique
- Use mL, rather than a handwritten abbreviation that might be misread. Unit symbols do not take a plural s.
- Write a space between the number and unit: 25 mg. Use a leading zero: 0.5 mg. Avoid unnecessary trailing zeros in medication directions.
- Use an appropriate calibrated measuring device. A household spoon is unsuitable for precise dosing.
- For a clear liquid with a concave meniscus, read the bottom of the meniscus at eye level using the device instructions. An unsuitable viewing angle causes parallax error.
- Select a balance and container appropriate for the mass. Tare correctly and observe the established minimum measurable quantity.
Memory trick: Big unit to small unit: multiply. Small unit to big unit: divide. Check this with 1 g = 1000 mg before converting a decimal quantity.
2.3 Scientific Notation, Precision and Rounding
Scientific notation writes a number as a × 10^n, where 1 ≤ |a| < 10 and n is an integer. It makes small masses and large conversion factors easier to read.
| Ordinary form | Scientific form |
|---|---|
| 2500 | 2.5 × 10³ |
| 0.00025 | 2.5 × 10^(-4) |
| 0.006 g | 6 × 10^(-3) g |
| 1000 | 1 × 10³ |
How to Write It
- Step 1: Move the decimal point until one non-zero digit is to its left.
- Step 2: Count the number of places moved.
- Step 3: Moving left gives a positive exponent; moving right gives a negative exponent.
- Step 4: Expand the expression once to verify the original value.
Example: 0.000045 g = 4.5 × 10^(-5) g = 45 micrograms. A negative exponent means a small positive quantity; it does not mean a negative mass.
Arithmetic in Scientific Notation
For multiplication, multiply coefficients and add exponents:
(2 × 10³) × (3 × 10^(-2)) = 6 × 10¹ = 60.
For division, divide coefficients and subtract exponents:
(6 × 10^(-3)) / (2 × 10²) = 3 × 10^(-5).
For addition or subtraction, first express both numbers with the same exponent.
Accuracy Versus Precision
| Term | Meaning |
|---|---|
| Accuracy | Closeness to the correct or accepted value |
| Precision | Agreement between repeated measurements |
| Resolution | Smallest increment displayed or distinguished |
| Significant figures | Digits that communicate the precision of a stated value |
A balance may repeatedly show similar readings but still have a calibration error. Repetition alone does not prove accuracy. Keep extra digits during calculations, then round according to the question and the measuring device. Exact conversion factors such as 1000 mg per g do not limit significant figures.
Rounding example: A calculated volume of 3.333… mL may be reported as 3.33 mL in a numerical exercise. The practical measured quantity must match the available calibrated device and the permitted procedure; do not imply unrealistic measuring precision.
2.4 Percentage Strength: Meaning and Calculation
Percentage means an amount in every 100 units of the final preparation. The concentration basis must be stated because mass and volume are different quantities.
| Expression | Meaning | Example |
|---|---|---|
| % w/w | g in 100 g of final preparation | 2% w/w = 2 g in 100 g |
| % w/v | g in 100 mL of final preparation | 2% w/v = 2 g in 100 mL |
| % v/v | mL in 100 mL of final preparation | 2% v/v = 2 mL in 100 mL |
General relationship:
% strength = (amount of ingredient / final quantity) × 100
Use the appropriate units for the stated basis. For % w/v, ingredient mass is in g and final volume is in mL.
Worked Example: 2% w/v, 150 mL
- Step 1: 2% w/v means 2 g in each 100 mL.
- Step 2: Required mass = (2 / 100) × 150 = 3 g.
- Step 3: Dissolve the solute in a suitable portion of vehicle, following the formulation procedure.
- Step 4: Make the preparation up to a final volume of 150 mL. Do not add 150 mL of vehicle to the solute.
Worked Example: 5% w/w, 40 g
- Step 1: API mass = (5 / 100) × 40 = 2 g.
- Step 2: For an assumed two-component preparation, base mass = 40 – 2 = 38 g.
- Step 3: Check 2 g / 40 g × 100 = 5% w/w.
Worked Example: 10% v/v, 250 mL
The required liquid ingredient volume is (10 / 100) × 250 = 25 mL. Add sufficient compatible vehicle to make 250 mL final volume. Final volume is not always the arithmetic sum of the separate liquids.
Memory trick: The denominator describes the finished preparation. “2% w/v” does not mean 2 g plus 100 mL of water; it means 2 g contained in 100 mL of the final product.
2.5 Ratio Strength and Concentration Expressions
Ratio strength expresses one part of ingredient in a stated number of parts of final preparation. A ratio such as 1:1000 is incomplete for a liquid unless the basis is identified.
Conversion Relationships
- For 1:N w/v: 1 g in N mL; % w/v = 100 / N.
- For 1:N w/w: 1 g in N g; % w/w = 100 / N.
- For 1:N v/v: 1 mL in N mL; % v/v = 100 / N.
- From a percentage P on the same basis: N = 100 / P.
| Strength | Equivalent on a w/v basis |
|---|---|
| 1:100 | 1% w/v = 10 mg/mL |
| 1:1000 | 0.1% w/v = 1 mg/mL |
| 1:10 000 | 0.01% w/v = 0.1 mg/mL |
| 1:500 | 0.2% w/v = 2 mg/mL |
Worked Example: Mass in a Ratio Solution
- Step 1: Required: 200 mL of 1:4000 w/v.
- Step 2: 1 g is contained in 4000 mL, so mass = 200 / 4000 = 0.05 g.
- Step 3: 0.05 g = 50 mg. Check: 50 mg / 200 mL = 0.25 mg/mL.
Percentage to mg/mL
For % w/v only, P% = 10P mg/mL. Therefore 0.25% w/v = 2.5 mg/mL. To reverse it, divide the mg/mL value by 10. This shortcut cannot be used unchanged for % w/w or % v/v.
Parts per Million
For a mass fraction, 1 ppm = 1 mg/kg. In a dilute aqueous solution with density close to 1 kg/L, 1 ppm is approximately 1 mg/L. State the density assumption when using this approximation. Do not confuse mg/L with mg/mL: they differ by a factor of 1000.
Smaller denominator, stronger solution: On the same ratio basis, 1:100 is stronger than 1:1000. Always translate a ratio into an amount per final quantity before performing a dose or dilution calculation.
2.6 Dilution of Solutions and Conservation of Solute
Dilution reduces concentration by increasing the final quantity with a compatible diluent. When the amount of solute remains unchanged, C₁V₁ = C₂V₂ for compatible volume-based concentration units.
Diagram labels: Stock aliquot: 10 mL at 10% w/v; solute present: 1 g. Add compatible diluent. Final preparation: 100 mL at 1% w/v; solute present: 1 g. Make up to volume; do not add 100 mL.
Explanation: The stock portion contains 1 g of solute. After making up to 100 mL, the same 1 g is present at 1% w/v; the calculation assumes no solute loss or reaction.
Worked Example: 10% Stock to 1%, 100 mL
- Step 1: C₁ = 10%, C₂ = 1%, V₂ = 100 mL; both concentrations are w/v.
- Step 2: V₁ = C₂V₂ / C₁ = (1 × 100) / 10 = 10 mL.
- Step 3: Measure 10 mL of stock and add sufficient compatible diluent to make 100 mL final volume.
- Step 4: Check the stock portion contains (10 g / 100 mL) × 10 mL = 1 g; 1 g / 100 mL = 1% w/v.
Dilution Factor
Dilution factor = final volume / stock aliquot volume = C₁ / C₂.
Here the factor is 100 / 10 = 10. A tenfold dilution makes the concentration one-tenth of its original value.
Serial Dilution
A 1 mL aliquot made up to 10 mL is a tenfold dilution. Taking 1 mL of that diluted preparation and again making up to 10 mL gives a total dilution factor of 10 × 10 = 100. From a 1 mg/mL stock, the final concentration is 0.01 mg/mL.
- Mix each stage before withdrawing its aliquot.
- Use a fresh, appropriate measuring device and identify every container.
- Multiply the dilution factors; do not add them.
Scope of C₁V₁ = C₂V₂: Use the same concentration basis on both sides. For mass-based mixtures, conserve mass with C₁m₁ = C₂m₂. Evaporation, precipitation, degradation or chemical reaction requires additional reasoning; simple dilution assumptions may no longer hold. If the desired concentration exceeds the stock concentration, adding plain diluent cannot achieve it. A stronger stock, additional solute or an appropriate concentration process would be required.
2.7 Alligation: Medial and Alternate Methods
Alligation solves mixture problems involving strengths on the same basis. Alligation medial finds the strength of known quantities mixed together. Alligation alternate finds the relative quantities needed to obtain a desired intermediate strength.
Alligation Medial: Weighted Average
Final strength = sum of (quantity × strength) / total quantity.
For w/w preparations, use masses. For volume-based preparations, the simple volume form assumes that the final mixture volume is the sum used in the calculation.
Example: mix 20 g of 5% w/w ointment with 30 g of 15% w/w ointment.
API = 20 × 0.05 + 30 × 0.15 = 1 + 4.5 = 5.5 g.
Final mass = 50 g.
Strength = 5.5 / 50 × 100 = 11% w/w.
Diagram labels: Starting strengths: high 20%, low 5%; desired 10%. High: 5 parts, 10 – 5 = 5. Low: 10 parts, 20 – 10 = 10. High:low = 5:10 = 1:2. For 60 g total: 20 g high + 40 g low.
Explanation: Subtract diagonally: desired minus low gives the parts of high-strength preparation, while high minus desired gives the parts of low-strength preparation.
Alligation Alternate: Stepwise Solution
- Step 1: High strength H = 20%; low strength L = 5%; desired D = 10%.
- Step 2: Parts of high = D – L = 10 – 5 = 5 parts.
- Step 3: Parts of low = H – D = 20 – 10 = 10 parts.
- Step 4: High:low = 5:10 = 1:2.
- Step 5: For 60 g total, high = 60 × 1/3 = 20 g; low = 60 × 2/3 = 40 g.
- Step 6: Check API = 20 × 0.20 + 40 × 0.05 = 6 g; 6/60 × 100 = 10% w/w.
Special Cases and Limits
- A plain compatible diluent has 0% active ingredient; a pure ingredient can be treated as 100% on the appropriate mass basis.
- The desired strength must lie between the two starting strengths. Negative differences indicate an unsuitable pair or an incorrect arrangement.
- The arithmetic gives proportions, not evidence of formulation compatibility or blend uniformity.
- For liquids with appreciable contraction or expansion on mixing, account for actual final volume rather than assuming additivity.
Memory trick: Opposite difference gives the part. If the desired strength is closer to the low strength, more low-strength preparation is needed. Use this sense check before accepting the ratio.
2.8 Proof Spirit and Alcoholic Strength
Proof spirit is a historical way of expressing ethanol strength. The traditional British/Indian teaching convention treats proof spirit as approximately 57.1% v/v ethanol at 60°F (about 15.6°C). Proof strength is convention-dependent; it is not a universal synonym for percentage alcohol.
| Convention | Relationship |
|---|---|
| Traditional proof convention | 100 proof corresponds to about 57.1% v/v ethanol |
| US proof | Proof number = 2 × % ABV |
| % v/v / ABV | mL ethanol in 100 mL final preparation at the stated reference conditions |
Traditional Calculation Relationships
- Proof strength P = (% v/v × 100) / 57.1. Some questions use 57.15; use the constant supplied in that question consistently.
- % v/v = P × 57.1 / 100.
- Degrees over proof (OP) = P – 100, when P exceeds 100.
- Degrees under proof (UP) = 100 – P, when P is below 100.
Worked Example: 70% v/v Ethanol
- Step 1: Traditional proof strength = 70 × 100 / 57.1 = 122.59 proof approximately.
- Step 2: Degrees OP = 122.59 – 100 = 22.59° OP approximately.
- Step 3: Check: 122.59 × 57.1 / 100 ≈ 70% v/v.
Worked Example: 25° UP
- Step 1: Proof strength = 100 – 25 = 75 proof.
- Step 2: Ethanol strength = 75 × 57.1 / 100 = 42.825% v/v, or about 42.83% v/v.
Worked Example: Dilution in Proof Units
Find the volume of 140-proof spirit required for 250 mL of 70-proof spirit, using the same proof convention.
V₁ = (70 × 250)/140 = 125 mL.
Measure the stock and make up to 250 mL after mixing and temperature equilibration as required. Ethanol-water volumes are not strictly additive.
Avoid the convention error: A solution of 40% ABV is 80 US proof, but about 70.05 traditional proof using 57.1. “20° OP” means 120 traditional proof, not 20% ethanol.
2.9 Isotonic Solutions: Osmosis and Cell Response
Osmosis is movement of water across a selectively permeable membrane in response to an osmotic gradient. Osmotic pressure is the pressure required to prevent that movement. Isotonic describes a solution that produces no sustained net change in cell volume relative to the reference cells or tissue. Hypotonic solutions promote water entry into cells; hypertonic solutions promote water loss from cells.
Diagram labels: Hypotonic: water enters; swelling. Isotonic: stable, no sustained net volume change. Hypertonic: water leaves; shrinkage.
Explanation: Arrows show the net direction of water movement for the illustrated idealised condition. Cell outlines are schematic; tonicity depends on the membrane and the effective solutes.
| Solution | Net response | Illustrated consequence |
|---|---|---|
| Hypotonic | Water enters cell | Swelling; excessive entry may cause lysis |
| Isotonic | No sustained net volume change | Cell volume remains approximately stable |
| Hypertonic | Water leaves cell | Shrinkage; red cells may crenate |
Tonicity Versus Osmolarity
Osmolarity counts osmotically active particles per litre of solution; osmolality counts particles per kilogram of solvent. Tonicity concerns the sustained effect on cell volume and depends on solutes that are effectively restricted by the relevant membrane. An isoosmotic solution is therefore not automatically isotonic if its solute enters cells readily.
Pharmaceutical Importance
- Tonicity is important for preparations in contact with sensitive tissues, including many ophthalmic and parenteral products.
- A conventional teaching benchmark is 0.9% w/v sodium chloride. A freezing-point depression of about 0.52°C is commonly used for calculations aimed at matching physiological fluids.
- The intended route, formulation and clinical purpose determine the actual product requirements. Not every parenteral preparation is formulated at exactly 0.9% sodium chloride equivalence.
Concept check: An isotonic solution is not automatically sterile, chemically stable or free of pyrogens. Tonicity is one quality attribute; it does not replace the other requirements of the dosage form.
2.10 Isotonicity Calculations: Sodium Chloride Equivalent
The sodium chloride equivalent (E value) is the mass of sodium chloride producing an equivalent osmotic effect to 1 g of the specified ingredient under the stated conditions. Use the value for the exact substance and chemical form.
Basic Relationship
For V mL final volume, the target NaCl-equivalent mass at the conventional 0.9% benchmark is 0.009 × V g. Each ingredient contributes w × E g of NaCl equivalence, where w is its mass in g.
Formula: NaCl to add (g) = 0.009V – Σ(wE)
V: final mL; w: ingredient g; E: stated NaCl equivalent.
Sum the contributions of all relevant solutes, including other formulation ingredients.
Worked Example: One Ingredient
Prepare 30 mL of a 1% w/v fictional Drug X solution. The question supplies E = 0.20 and assumes the method is suitable.
- Step 1: Drug mass = (1/100) × 30 = 0.30 g.
- Step 2: Target NaCl equivalence = 0.009 × 30 = 0.270 g.
- Step 3: Contribution from Drug X = 0.30 × 0.20 = 0.060 g.
- Step 4: NaCl to add = 0.270 – 0.060 = 0.210 g.
- Step 5: Check: (0.060 + 0.210)/30 × 100 = 0.9% w/v NaCl equivalence.
Worked Example: Two Solutes
A 50 mL preparation contains 0.50 g of ingredient A, E = 0.15, and 0.10 g of ingredient B, E = 0.20.
Target = 0.009 × 50 = 0.450 g.
Contributions = (0.50 × 0.15) + (0.10 × 0.20) = 0.095 g.
NaCl required = 0.450 – 0.095 = 0.355 g.
Interpretation of the Result
- A positive result indicates additional NaCl equivalence is needed, provided the adjusting agent is suitable.
- A zero result means no further NaCl is required by this approximation.
- A negative result means the existing osmotic contribution exceeds the target. Do not report a negative mass to add; reconsider volume or composition using the permitted formulation procedure.
E values and osmotic effects depend on the specified substance and conditions. A salt, hydrate or different chemical form must not be assigned another substance’s E value without justification.
2.11 Other Isotonicity Methods and Worked Comparisons
Freezing-Point Depression Method
Dissolved particles lower the freezing point of a solvent. For a conventional target depression of 0.52°C, calculate the existing depression and then the additional contribution required. This estimates an isoosmotic condition and requires the tonicity assumptions to be appropriate.
If a 1% w/v solution of the adjusting agent causes a depression b°C, and the existing preparation causes a°C depression, then:
Adjusting-agent concentration (% w/v) = (0.52 – a) / b
The concentrations and depression data must use the same basis.
Worked Example: Supplied Freezing-Point Data
- Step 1: Final volume = 100 mL; existing depression a = 0.12°C. The question supplies b = 0.576°C for 1% w/v NaCl.
- Step 2: Remaining depression = 0.52 – 0.12 = 0.40°C.
- Step 3: NaCl concentration = 0.40 / 0.576 = 0.6944% w/v.
- Step 4: For 100 mL, add approximately 0.694 g NaCl, subject to the stated formulation assumptions.
White-Vincent Method
This method first calculates the volume that the drug and other relevant solutes can make isotonic with water. The preparation is then brought to the required final volume with a suitable isotonic vehicle.
White-Vincent formula: Viso (mL) = Σ(wE) / 0.009 = 111.1 × Σ(wE)
The factor 111.1 mL/g is approximately 1/0.009. Use g for ingredient masses.
Worked Example: White-Vincent
- Step 1: Use 0.30 g of Drug X, E = 0.20; required final volume is 30 mL.
- Step 2: Viso = 111.1 × 0.30 × 0.20 ≈ 6.67 mL.
- Step 3: Prepare the drug solution with water to a total volume of 6.67 mL, following the suitable preparation method.
- Step 4: Use compatible isotonic vehicle to make the total volume 30 mL. Plain water to 30 mL would remove the calculated isotonic condition.
Sprowls Method
The Sprowls method uses tabulated volumes related to the White-Vincent approach, commonly the isotonic volume produced by 0.3 g of a substance. If the supplied table uses that basis:
Viso = (w/0.3) × tabulated volume
Confirm the table basis before calculating.
| Method | What is calculated |
|---|---|
| NaCl equivalent | Mass of NaCl needed after solute contributions |
| Freezing-point depression | Additional osmotic contribution from stated depression data |
| White-Vincent | Initial isotonic volume; then add isotonic vehicle |
| Sprowls | Initial isotonic volume from a supplied table |
Same target, different working data: Do not mix an E value with a freezing-point-depression value as though they were the same quantity. State the method, units and supplied constants before substituting.
2.12 Geometric Dilution: Uniform Mixing of Powders
Geometric dilution is a stepwise mixing technique used to distribute a relatively small quantity of ingredient through a larger quantity of compatible diluent. It is different from diluting a liquid solution.
Diagram labels: 2 g blend: 1 g API + 1 g diluent. 4 g blend: add 2 g diluent; mix. 8 g blend: add 4 g diluent; mix. 16 g blend: add 8 g diluent; mix. API: 1 g; total diluent: 15 g.
Explanation: At each stage, mix thoroughly before adding the next portion. The additions of diluent are 1 g, 2 g, 4 g and 8 g; the total diluent is 15 g and the final blend is 16 g.
Procedure
- Step 1: Weigh the ingredient and total diluent accurately. Reduce lumps or particle-size differences as required by the permitted process.
- Step 2: Place the small-quantity ingredient in a suitable mortar.
- Step 3: Add approximately an equal amount of diluent and mix thoroughly by suitable trituration.
- Step 4: Add another diluent portion approximately equal to the current mixture and mix again.
- Step 5: Repeat until all diluent is incorporated. If the remaining diluent is less than a full stage, incorporate the remainder carefully.
- Step 6: Check recovery and uniformity requirements; divide or package the blend according to the formulation.
Worked Calculation
With 1 g API and 15 g diluent, the successive blend masses are 2, 4, 8 and 16 g.
API percentage = 1 / 16 × 100 = 6.25% w/w.
The ingredient mass is constant; the mixture mass increases.
Why Simple Bulk Mixing May Fail
- A small quantity poured into a large powder mass may remain concentrated in a local region.
- Particle size, density, shape, electrostatic effects and handling can promote segregation.
- Geometric dilution improves distribution but does not guarantee content uniformity; appropriate controls or tests are still required.
Memory trick: Mix, match the mixture, mix again. Compare each new portion with the mixture already present, rather than repeatedly adding the original ingredient mass. Use the prescribed mixing method for materials whose bulk densities differ substantially.
2.13 Posology: Definition and Factors Affecting Dose
Posology is the study of medicine doses. A dose is the amount administered at one time; a dosage regimen includes dose, route, frequency and duration. Dose selection depends on the medicine and the patient.
| Term | Meaning |
|---|---|
| Single dose | Amount at one administration |
| Daily dose | Total amount administered in 24 hours |
| Loading dose | Initial dose intended to establish a target exposure rapidly |
| Maintenance dose | Repeated dose intended to maintain appropriate exposure |
| Maximum dose | Upper permitted dose for the specified context |
Patient and Medicine Factors
- Age: Absorption, distribution, metabolism and excretion vary with development and ageing.
- Body weight and composition: Total, ideal or adjusted body weight may be relevant depending on the drug and dosing instructions.
- Body surface area: Used for selected regimens expressed in mg/m².
- Renal and hepatic function: Impaired elimination or metabolism may require an altered dose or interval.
- Route and formulation: Bioavailability and release pattern affect exposure.
- Interactions, tolerance and individual sensitivity: Response may change with other medicines or previous exposure.
- Clinical condition: Severity, treatment goal, pregnancy or lactation and other patient characteristics can alter suitability.
Read the Dose Basis
5 mg/kg/dose means 5 mg for each kg at every administration.
5 mg/kg/day means 5 mg for each kg over the entire day; division into individual doses depends on the stated schedule.
These are different instructions.
Calculation versus prescribing: A calculation converts an established dosing instruction into a quantity. It does not establish whether that instruction is clinically appropriate. Historical adult-dose scaling rules are examination methods and cannot replace medicine-specific paediatric dosing guidance.
2.14 Age-Based Dose Calculations: Historical Rules
Age-based rules estimate a fraction of an adult dose. They are historically important in pharmacy teaching but do not adequately represent all developmental differences between children and adults.
| Rule | Historical calculation |
|---|---|
| Young | Child dose = age in years / (age + 12) × adult dose |
| Fried | Infant dose = age in months / 150 × adult dose |
| Dilling | Child dose = age in years / 20 × adult dose |
Young’s Rule: Worked Example
A question gives age 6 years and an adult dose of 300 mg for fictional Drug A.
- Step 1: Fraction = 6 / (6 + 12) = 6/18 = 1/3.
- Step 2: Estimated child dose = (1/3) × 300 = 100 mg.
- Step 3: Label the result as a historical-rule estimate, not an independently validated prescription.
Fried’s Rule: Worked Example
A question gives age 9 months and adult dose 200 mg.
- Step 1: Use months: fraction = 9/150 = 0.06.
- Step 2: Estimated infant dose = 0.06 × 200 = 12 mg.
Dilling’s Rule: Worked Example
For an age of 10 years and adult dose of 200 mg, the fraction is 10/20 = 0.5 and the historical estimate is 100 mg. Use the particular rule requested in the exercise; different rules can give different estimates.
Limitations
- Age alone does not provide actual body weight, organ function, drug clearance or therapeutic response.
- An adult dose may be unsuitable as the starting point for a paediatric medicine.
- Neonates and infants have marked developmental differences; a simple proportional rule cannot describe them reliably.
Memory aids: Young: years plus twelve. Fried: months over 150. Dilling: years over twenty. Keep the rule name and the age unit together to avoid substituting months into a years-based rule.
2.15 Weight-Based Calculations and Liquid Dose Volumes
Clark’s Historical Rule
Child dose = body weight in lb / 150 × adult dose.
If the exercise uses kg, convert to lb with the stated conversion. A traditional alternative uses weight in kg / 70; this is an approximation and is not exactly identical to the 150-lb formula.
Worked example: weight 44 lb and adult dose 300 mg give:
(44/150) × 300 = 88 mg.
Using 20 kg / 70 would give 85.71 mg; do not treat the denominators as exact equivalents.
Direct mg/kg/dose Calculation
For a supplied medicine-specific instruction:
Dose (mg) = stated mg/kg/dose × selected body weight (kg)
Use the weight basis specified for that medicine.
- Step 1: Fictional Drug B is specified in an exercise at 5 mg/kg/dose; weight = 18 kg.
- Step 2: Dose = 5 × 18 = 90 mg per dose.
- Step 3: The fictional liquid contains 30 mg/mL. Required volume = 90 / 30 = 3 mL per dose.
- Step 4: Check 3 mL × 30 mg/mL = 90 mg and compare with any supplied maximum or regimen limit.
Direct mg/kg/day Calculation
An exercise specifies fictional Drug C at 12 mg/kg/day, weight 20 kg, divided into three equal doses.
- Step 1: Total daily dose = 12 × 20 = 240 mg/day.
- Step 2: Each dose = 240 / 3 = 80 mg.
- Step 3: For a fictional liquid of 40 mg/mL, volume = 80 / 40 = 2 mL per dose.
- Step 4: Daily check: 80 × 3 = 240 mg/day. The daily dose was divided once, not multiplied by the number of doses.
Volume formula: Volume per dose (mL) = required dose (mg) / concentration (mg/mL)
If a label states 100 mg in 5 mL, first calculate concentration = 100/5 = 20 mg/mL.
Dose and Supply Quantity
For 2 mL per dose, three doses daily for five days:
Calculated volume used = 2 × 3 × 5 = 30 mL.
Actual supply follows the prescription, product packaging and authorised dispensing procedure. A supply calculation does not change the prescribed regimen.
2.16 Body-Surface-Area-Based Calculations
Body surface area (BSA) is an estimated external body area expressed in m². It incorporates height and weight and is used in selected dosing regimens.
Diagram labels: Height and weight: 120 cm; 30 kg. BSA = sqrt[(120 × 30)/3600] = 1.00 m². Rate × BSA: 50 mg/m² × 1.00 m² = 50 mg. Assumed exercise rate; not a prescribed regimen.
Explanation: The example uses 120 cm and 30 kg to obtain 1.00 m². Multiplying by an assumed 50 mg/m² gives a mathematical dose of 50 mg.
Mosteller formula: BSA (m²) = √[(height in cm × weight in kg) / 3600]
The square root applies to the entire product divided by 3600. Convert metres to cm before substitution.
Worked Example
- Step 1: Height = 120 cm; weight = 30 kg.
- Step 2: Multiply: 120 × 30 = 3600.
- Step 3: Divide by 3600: 3600/3600 = 1.
- Step 4: Take the square root: BSA = √1 = 1.00 m².
- Step 5: At the fictional exercise rate of 50 mg/m², dose = 50 × 1.00 = 50 mg.
Historical Scaling from an Adult Dose
A separate teaching relationship is:
Estimated child dose = (child BSA / 1.73 m²) × adult dose
This uses 1.73 m² as the conventional adult reference area.
For BSA 0.865 m² and adult dose 200 mg:
(0.865/1.73) × 200 = 100 mg.
Do not confuse this adult-dose fraction with a prescribed mg/m² regimen. The first scales an adult amount; the second multiplies the specified dose rate by the patient’s BSA.
| Basis | Calculation | Final unit |
|---|---|---|
| mg/kg | Rate × weight in kg | mg |
| mg/m² | Rate × BSA in m² | mg |
| Adult-dose fraction | Dimensionless fraction × adult mg | mg |
Limits and Checks
- Verify current height and weight and the formula specified by the regimen.
- A calculated BSA does not automatically correct for organ dysfunction, obesity or unusual pharmacokinetics.
- Check any dose cap, dose interval or clinical adjustment supplied in the authorised instructions.
Memory trick: Height × weight, divide by 3600, then square root. For a dose rate in mg/m², multiply by BSA; do not divide by BSA.
2.17 Routes of Administration: Principles and Comparison
A route of administration is the path or site through which a medicine is given. Route affects onset, bioavailability, local or systemic action and the suitability of a formulation.
Enteral Routes
| Route | Description and examples | Key point |
|---|---|---|
| Oral | Swallowed tablets, capsules or liquids | Convenient; absorption and first-pass metabolism can vary |
| Sublingual | Placed under the tongue | Mucosal absorption may provide rapid systemic delivery |
| Buccal | Placed against cheek mucosa | Local or systemic action depending on formulation |
| Rectal | Suppositories or rectal liquids | Useful for selected local/systemic uses; absorption variable |
Enteral generally refers to delivery involving the gastrointestinal tract, with oral, buccal/sublingual and rectal routes commonly grouped in basic pharmacy classification. Sublingual and buccal absorption occurs through the oral mucosa, rather than relying on swallowing.
Parenteral Injection Routes
| Route | Site | Important distinction |
|---|---|---|
| Intravenous (IV) | Into a vein | Direct systemic delivery; no absorption step into blood |
| Intramuscular (IM) | Into muscle | Absorption depends on formulation and site |
| Subcutaneous (SC) | Into tissue beneath skin | Selected formulations; rate depends on drug and perfusion |
| Intradermal (ID) | Within the dermis | Small volumes for selected tests or products |
Parenteral commonly means injection routes that bypass the gastrointestinal tract. They require route-appropriate sterile products, trained administration and compatible formulation characteristics. An oral product must not be assumed suitable for injection.
Other Important Routes
| Route | Examples and purpose |
|---|---|
| Inhalation | Aerosols or dry powders delivered to the respiratory tract; local or systemic action |
| Topical skin | Creams, ointments, gels and lotions, usually for local action |
| Transdermal | Designed patches or systems for systemic delivery through skin |
| Ophthalmic | Eye preparations; route-specific sterility and suitability |
| Otic | Ear drops for appropriate local use |
| Nasal | Drops or sprays for local or selected systemic action |
| Vaginal | Pessaries, creams or gels for selected local/systemic effects |
Choosing a Route
- Consider the target site, urgency, drug stability, absorption and available formulations.
- Consider swallowing ability, vomiting, consciousness, age and patient preference.
- Consider local irritation, equipment, sterility and the skill needed for administration.
Topical versus transdermal: Both involve skin application, but topical commonly aims at local action while transdermal is designed to deliver drug into systemic circulation. Product purpose and design determine the distinction.
2.18 Dosage Forms: Definition and Classification
A dosage form is the physical pharmaceutical preparation in which a medicine is supplied for administration. It combines the API with an appropriate design and, where needed, excipients to deliver a usable dose.
Diagram labels: Solid: tablets, capsules, powders. Liquid: solutions, suspensions, emulsions. Semisolid: ointments, creams, gels, pastes. Aerosol/inhaled: aerosols and inhaled powders. Route and release pattern are additional axes.
Explanation: The examples illustrate broad categories rather than every possible dosage form. Route, sterility and release pattern provide additional classification axes.
Why Dosage Forms Are Needed
- Provide a measurable dose and improve dose reproducibility.
- Support stability during storage and protect sensitive ingredients.
- Allow local targeting or systemic delivery through a suitable route.
- Improve taste, handling and acceptability where appropriate.
- Control release when the formulation is designed and validated for that purpose.
| Category | Examples | General feature |
|---|---|---|
| Solid | Powders, granules, tablets, capsules | Usually measured or divided by mass or unit count |
| Liquid | Solutions, suspensions, emulsions | Dose often measured by volume |
| Semisolid | Ointments, creams, gels, pastes | Applied in an appropriate amount to a site |
| Aerosol / inhaled presentation | Metered-dose aerosols and inhaled powders | Device and particle delivery are important |
Additional Classification
- By route: Oral, parenteral, ophthalmic, topical and other route-specific forms.
- By release: Immediate-release, delayed-release and extended-release formulations.
- By dose presentation: Single-dose units or multidose containers.
- By sterility: Forms requiring sterility versus forms with appropriate nonsterile microbial limits.
Important Distinctions
| Compare | Difference |
|---|---|
| Solution / suspension | Dissolved solute versus dispersed insoluble particles |
| Suspension / emulsion | Dispersed solid particles versus one liquid dispersed in another |
| Immediate / extended release | Prompt release versus designed release over a longer period |
| Dosage form / route | Physical preparation versus the path of administration |
A tablet does not necessarily imply immediate release, and a liquid does not necessarily imply a solution. “Injection” is a route-related product category that may be a solution, suspension or another suitable presentation. Identify the actual formulation before calculating or administering.
Product integrity: Do not assume that every tablet can be crushed or every capsule opened. Modified-release or enteric-coated products can depend on their structure to provide the intended release. Suitability is product-specific.
2.19 Active Pharmaceutical Ingredients: Role and Desirable Properties
An active pharmaceutical ingredient (API) is a substance intended to provide the pharmacological or other direct therapeutic effect of a medicine. In a drug product, the API is the component responsible for the intended activity.
Example: paracetamol is the API in a paracetamol tablet. The API amount is not the same as the total tablet mass, because the tablet may also contain several formulation ingredients.
Desirable Characteristics
- Identity and purity: Correct chemical or biological identity, appropriate potency and controlled impurities.
- Therapeutic suitability: The intended activity with an acceptable benefit-risk profile at the appropriate dose.
- Stability: Adequate resistance to degradation under intended manufacturing, storage and use conditions.
- Solubility and dissolution: Behaviour suitable for the chosen dosage form and release requirements.
- Particle and solid-state properties: Controlled particle size, crystal form or other attributes where they affect manufacture or performance.
- Compatibility: Appropriate interaction with other ingredients and the container system.
- Manufacturability: Properties suitable for consistent processing and uniform dose distribution.
- Quality consistency: Reproducible material characteristics and traceable supply.
These are desirable attributes, not a claim that every API must dissolve readily in water or be stable under every condition. A poorly water-soluble API may still be useful if an appropriate formulation delivers it effectively.
Importance of API Properties
- The dose determines how much API must be present per unit or measured volume.
- Particle size and solid form may influence dissolution and processing.
- Sensitivity to moisture, light or oxygen influences formulation and packaging.
- Solubility influences whether a liquid can be a solution or may need a suspension or another design.
Strength and Chemical Form
A medicine may contain an API as a salt, hydrate or other specified form. The labelled strength may refer to the base or another defined active moiety. Use the stated strength basis and any required equivalence factor; do not interchange chemical forms solely because their names are similar.
API versus finished product: The API is an ingredient. The drug product is the finished dosage form containing that ingredient, with its formulation, packaging and performance requirements.
2.20 Excipients: Functions and Examples
An excipient is a formulation component other than the active ingredient, intentionally used to support manufacture, stability, administration, acceptability or delivery. “Inactive” refers to its intended role in the product; it does not mean that it is irrelevant or incapable of causing an effect.
| Function | Purpose | Examples |
|---|---|---|
| Diluent / filler | Provide bulk | Lactose, microcrystalline cellulose |
| Binder | Help particles form a coherent mass | Povidone, starch paste |
| Disintegrant | Help a tablet break up | Croscarmellose sodium, sodium starch glycolate |
| Lubricant | Reduce friction during tablet ejection | Magnesium stearate |
| Glidant | Improve powder flow | Colloidal silicon dioxide |
| Solvent / vehicle | Carry or dissolve ingredients | Purified water; suitable cosolvent systems |
| Suspending agent | Help dispersed particles remain distributable | Sodium carboxymethylcellulose, xanthan gum |
| Emulsifier | Help stabilise a liquid-liquid dispersion | Polysorbates and other suitable surfactants |
| Preservative | Limit microbial growth when appropriate | Suitable parabens or benzoates |
| Antioxidant | Reduce oxidative degradation | Ascorbic acid or suitable sulfites |
| Buffer | Help control pH | Appropriate phosphate or citrate systems |
| Sweetener / flavour | Improve acceptability | Sucrose or a suitable non-sugar sweetener |
| Coating material | Protect, mask taste or alter release | Suitable cellulose derivatives |
Examples indicate common uses, not a universal formula. One material can have more than one function, and its concentration or grade can change its behaviour. Water used in manufacture must have the quality required for the preparation.
Function Is Product-Dependent
- A surfactant may assist wetting, solubilisation or emulsification depending on the system.
- A polymer may act as a binder, film former or release-controlling material.
- A preservative works only if its type, concentration and available activity are suitable for the product.
- A substance may be active in one medicine and an excipient in another, depending on the intended effect.
Lubricant, glidant and disintegrant: Lubricant: reduce friction. Glidant: improve flow. Disintegrant: promote breakup. These functions are distinct even when a material has several effects.
2.21 Excipient Selection and API-Excipient Comparison
Diagram labels: API: intended activity. Excipients: formulation support. Finished dosage form: quality, stability and delivery. Suitability is assessed for the whole product.
Explanation: The API provides the intended activity. Excipients help the product be manufactured, remain suitable and deliver the API; the entire formulation must be evaluated.
Desirable Excipient Characteristics
- Safety for the intended use: Appropriate for route, amount, exposure, age group and patient population.
- Compatibility: No unacceptable reaction or interaction with the API, other excipients or the container.
- Functional performance: Performs its intended role throughout the product’s shelf life.
- Quality: Suitable identity, purity and microbiological characteristics.
- Consistency: Controlled grade and relevant material attributes for reproducible manufacture.
- Practical suitability: Feasible processing, supply, storage and cost without compromising quality.
Why Selection Matters
A tablet needs enough mechanical strength for handling but must also release the API as intended. Too much binder or unsuitable lubrication can change product performance. In a liquid, an excipient that improves solubility may also alter taste, pH or tolerability. Selection therefore considers the whole formulation.
| Aspect | API | Excipient |
|---|---|---|
| Primary intended role | Therapeutic or pharmacological activity | Support formulation or delivery |
| Quantity basis | Dose or labelled strength | Functional amount appropriate to product |
| Examples | Paracetamol; a specified antibiotic substance | Binder, filler, vehicle, preservative |
| Quality concern | Potency, impurities and relevant material properties | Purity, compatibility and function |
| Can affect performance? | Yes | Yes; not merely decorative material |
Stepwise Selection
- Step 1: Identify the dosage form, route and desired product performance.
- Step 2: Define the function needed, such as binding or pH control.
- Step 3: Choose candidate materials and suitable grades.
- Step 4: Evaluate safety, compatibility and functional behaviour at the proposed amount.
- Step 5: Confirm processing, stability, packaging and final-product performance.
No universal ideal ingredient: An excipient suitable for one route or age group may be unsuitable for another. Previous use in a product does not establish unrestricted suitability at every concentration. Choose by function, route, exposure and compatibility.
2.22 Integrated Numerical Problems and Error Analysis
Problem 1: Diluted Liquid and Measured Dose
A fictional stock contains 20 mg/mL. Prepare 100 mL at 2 mg/mL, then calculate the volume containing a stated exercise dose of 6 mg.
- Step 1: V₁ = (2 × 100)/20 = 10 mL stock.
- Step 2: Make up to 100 mL with suitable diluent.
- Step 3: Dose volume = 6/2 = 3 mL.
- Step 4: Stock solute = 20 × 10 = 200 mg; diluted solute = 2 × 100 = 200 mg.
Problem 2: Scale a Formulation
A teaching formula for 100 g contains 4 g API, 6 g named excipient and base q.s. to 100 g. Prepare 25 g.
- Step 1: Scale factor = 25/100 = 0.25.
- Step 2: API = 4 × 0.25 = 1 g; excipient = 6 × 0.25 = 1.5 g.
- Step 3: Base = 25 – 1 – 1.5 = 22.5 g, assuming no other ingredients or process losses.
- Step 4: Check API remains 1/25 × 100 = 4% w/w.
Problem 3: Alligation with Plain Base
To prepare 80 g of 3% w/w from 12% w/w preparation and plain base:
High:low = (3 – 0):(12 – 3) = 3:9 = 1:3.
Use 20 g of 12% preparation and 60 g of base.
Check active mass = 20 × 0.12 = 2.4 g; 2.4/80 × 100 = 3%.
Problem 4: Interpret a Negative Isotonicity Result
A 10 mL solution contains 0.5 g of ingredient with E = 0.30.
Target = 0.009 × 10 = 0.09 g.
Existing contribution = 0.5 × 0.30 = 0.15 g.
Calculated NaCl addition = -0.06 g.
This means the contribution already exceeds the target. Under the stated approximation, its initial isotonic volume is 0.15/0.009 = 16.67 mL; a required final volume of 10 mL cannot be obtained by adding NaCl.
Common Errors and Corrections
| Error | Correction |
|---|---|
| 1% w/v = 1 mg/mL | 1% w/v = 10 mg/mL |
| Add 100 mL water for 100 mL final product | Make up to 100 mL final volume |
| Use high – desired as parts of high | Parts of high = desired – low |
| Divide mg/kg/dose by daily frequency | Divide only when the instruction is mg/kg/day |
| Use height in metres in Mosteller formula | Convert height to cm |
| Assume “inactive” means no formulation effect | Evaluate excipient function and suitability |
2.23 Quick Revision: Formulas and Concept Checks
Core Formulas
| Purpose | Relationship |
|---|---|
| % w/v | mass g = (% × final mL)/100 |
| Ratio to percentage | % = 100/N for 1:N on same basis |
| % w/v to mg/mL | mg/mL = 10 × % w/v |
| Simple dilution | C₁V₁ = C₂V₂ |
| Dilution factor | Final volume / stock aliquot volume |
| Alligation alternate | High:low = (D – L):(H – D) |
| Traditional proof | P = % v/v × 100/57.1 |
| NaCl-equivalent method | NaCl g = 0.009V – Σ(wE) |
| White-Vincent | V iso = 111.1 × Σ(wE) |
| Weight dose | mg = mg/kg × weight kg |
| Liquid dose volume | mL = dose mg / mg per mL |
| Mosteller BSA | m² = √[(cm × kg)/3600] |
| Surface-area dose | mg = mg/m² × BSA m² |
Historical Rule Recall
- Young: years/(years + 12) × adult dose.
- Fried: months/150 × adult dose.
- Dilling: years/20 × adult dose.
- Clark: lb/150 × adult dose; kg/70 is a traditional approximation.
Concepts to Keep Separate
- Mass versus volume: Density is needed to connect them.
- Dose versus strength: Dose is the amount administered; strength is the amount per unit or quantity of product.
- mg/kg/day versus mg/kg/dose: Daily total versus each administration.
- Isoosmotic versus isotonic: Particle concentration versus sustained cell-volume effect.
- Liquid dilution versus geometric dilution: Concentration change versus stepwise powder mixing.
- Dosage form versus route: Product presentation versus the path of administration.
- API versus excipient: Intended activity versus formulation support; both influence product quality.
Final answer checklist: Have the units cancelled correctly? Is the final quantity correct? Is the concentration basis stated? Does a dilution become weaker? Is the mixture strength between the starting strengths? Was a daily dose divided only once?
One-minute recall: Convert 0.5 g to mg; express 1:1000 w/v in mg/mL; name three tonicity responses; state Young’s rule; distinguish topical from transdermal; name a binder, disintegrant and lubricant.
2.24 Possible Examination Questions and Numerical Practice
Very Short-Answer Questions
- Define pharmaceutical calculations, percentage strength, ratio strength and alligation.
- State the meaning of % w/w, % w/v and % v/v.
- Define proof spirit, isotonic solution, sodium chloride equivalent and posology.
- Write the Mosteller formula and state its input units.
- Define an API, an excipient, a dosage form and a route of administration.
- Differentiate dose per day from dose per administration.
Short-Answer Questions
- Explain metric conversions with examples and describe scientific notation.
- Explain dilution factor and serial dilution with a worked example.
- Distinguish alligation medial from alligation alternate.
- Explain the traditional proof convention and OP/UP calculations.
- Compare hypotonic, isotonic and hypertonic solutions.
- Explain the sodium chloride equivalent and White-Vincent methods.
- Describe geometric dilution step by step and explain its limitations.
- Explain factors affecting dose and the limitations of historical dose rules.
- Compare oral, IV, IM and SC routes.
- Classify dosage forms and compare API and excipient functions.
Long-Answer Questions
- Discuss percentage and ratio strength, dilution and alligation with labelled calculations.
- Explain isotonicity, sodium chloride equivalent, freezing-point depression and isotonic-volume methods with examples.
- Describe age-, weight- and BSA-based calculations, including units and dose-frequency interpretation.
- Explain routes of administration and classify dosage forms with examples.
- Discuss the definitions, desirable characteristics and importance of APIs and excipients.
Numerical Practice
| Question | Answer |
|---|---|
| 1. Convert 0.0035 g to micrograms. | 3500 micrograms |
| 2. Find mass for 80 mL of 1.5% w/v. | 1.2 g |
| 3. Convert 1:2500 w/v to % and mg/mL. | 0.04% w/v; 0.4 mg/mL |
| 4. Prepare 200 mL of 0.5% w/v from 5% w/v stock. | 20 mL stock; make up to 200 mL |
| 5. Mix 25% and 5% w/w to obtain 100 g of 10% w/w. | 25 g high + 75 g low |
| 6. Convert 30° UP using 57.1. | 70 proof; 39.97% v/v |
| 7. A 20 mL solution contains 0.2 g drug, E = 0.25. Find NaCl. | 0.13 g |
| 8. Find isotonic volume for 0.4 g drug, E = 0.18. | 8.00 mL |
| 9. Age 8 years, adult dose 250 mg: Young estimate. | 100 mg |
| 10. 15 kg at 4 mg/kg/dose; liquid 20 mg/mL. | 60 mg; 3 mL per dose |
| 11. 25 kg at 18 mg/kg/day in 3 doses. | 450 mg/day; 150 mg per dose |
| 12. Height 144 cm, weight 25 kg: Mosteller BSA. | 1.00 m² |
| 13. 0.90 m² at 40 mg/m². | 36 mg |
| 14. Blend 2 g ingredient with 30 g diluent. Find % w/w. | 6.25% w/w |
Answer Presentation
- Start each numerical answer with the supplied data and units.
- Write the formula before substitution, show the calculation and give the final unit.
- Finish with a short independent check using amount conservation, unit cancellation or an expected range.
- For descriptive answers, define the term, classify or compare it, explain the principle and add a relevant example.
Examination practice: syllabus-based questions, not examination predictions. Dose examples and assumed material data are calculation exercises.
Frequently Asked Questions
Where can I download AKTU B.Pharm First Year General Pharmacy Notes?
You can download unit-wise handwritten and typed notes directly from this page in PDF format.
Are these notes strictly according to the AKTU syllabus?
Yes, these notes cover all important units and topics prescribed by the latest AKTU syllabus.
Can I clear my semester exams using these notes?
Yes, combining these notes with previous year question papers is the best strategy to score high marks in semester exams.
Are these General Pharmacy notes free to download?
Yes, all resources on NotesGallery are completely free to view and download.
How frequently are the notes updated?
We regularly update our study materials and add new contributions from university toppers.